grounds and treatments have been reported in patients with coronary artery disease and cardiomyopathies, which are 2 of the leading causes of HF. 13-15 However, regional variations in Japanese patients with HF remain unclear, so we hypothesized that addressing such variations could potentially improve HF management and prognosis. Thus, the aim of the present study was to clarify regional variations in both clinical practice and prognosis of Japanese patients with HFrEF using the Japanese Registry of Acute Decompensated Heart Failure (JROADHF). 16
Methods
Study SettingThe JROADHF database is a retrospective, multicenter, H eart failure (HF) as a common clinical syndrome with high morbidity and mortality has been increasing worldwide, 1,2 so to improve the prognosis of patients with HF, task forces have summarized the accumulating evidence and proposed evidence-based treatments as guidelines. 3-6 The cardioprotective evidence is abundant for patients with HF with reduced ejection fraction (HFrEF) in particular, 3-6 but HF is a heterogeneous syndrome with various etiologic and pathophysiologic factors. 7,8 Regional variations in clinical practice and prognosis have been reported in the USA, Europe, and Asia, which suggests region-specific risk factors and gaps. 9,10 Japan has one of the fastest aging populations and the number of patients with HF is predicted to keep increasing. 11,12 In addition, regional variations in patients' back-